By this approach, we found that GSKJ4 treatment abrogated the expression of NOTCH3 and NOTCH1 at both gene and protein levels and reduced the transcription of Notch target gene DELTEX1 in T-ALL cells (Figures 4A,C). This evidence concerns the gene NOTCH3 and acute lymphoblastic leukemia.